Correction to: Prostate Cancer and Prostatic Diseases (2004) 7, 99–104. doi:10.1038/sj.pcan.4500705
Since the publication of the above paper, the authors have identified an error in the Development of more modern bisphosphonates section. The original sentence had the figures reversed. The corrected sentence should read:
The median time to the first skeletal event was 321 days with placebo, and 488 days for patients receiving zoledronic acid 4 mg (P=0.009).
Additional information
The online version of the original article can be found at 10.1038/sj.pcan.4500705
Rights and permissions
About this article
Cite this article
Coxon, J., Oades, G., Colston, K. et al. Erratum: Advances in the use of bisphosphonates in the prostate cancer setting. Prostate Cancer Prostatic Dis 7, 270 (2004). https://doi.org/10.1038/sj.pcan.4500758
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500758
